Atlas Trials

Evaluation of Vascular Toxicity of Immune Checkpoint Inhibitors in Patients Head and Neck or Lung Cancer

Clinical trial NCT05655663 · UNKNOWN

Trial details

NCT number
NCT05655663
Sponsor
Centre Henri Becquerel
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Head and Neck CancerLung Cancer
Start date
2022-12-20
Primary completion
2025-02-10
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.